Using Personalized Immunotherapies to Advance Melanoma Treatment

Melanoma, a potentially fatal type of skin cancer, presents as a prominent challenge in oncology, due to its significant mortality rates and aggressive nature. This emphasizes the immediate demand for new, effective treatments which address these obstacles, prompting additional research and a concerted effort to quickly find better treatment options. Personalized immunotherapy, which involves tailoring treatments to the unique characteristics of each patient, offers a promising solution. The integration of personalized immunotherapy into treatments both addresses the complexity of the cancer and enhances the effectiveness of therapies. This review underscores how utilizing personalized immunotherapy alongside immune checkpoint inhibitors, oncolytic viruses, and tumor-infiltrating lymphocyte therapy can significantly improve patient outcomes by effectively targeting and eliminating malignant melanoma tumors.